We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cardiac Stents Offer No Relief for Stable Angina

By HospiMedica International staff writers
Posted on 20 Nov 2017
A new study has concluded that percutaneous coronary intervention (PCI) is no better than a placebo procedure at providing relief to stable angina patients.

Researchers at Imperial College London (ICL; United Kingdom), Queen Mary, University of London (QMUL; United Kingdom), and other institutions conducted a blinded trial involving 230 patients with severe single-vessel stenosis, who were randomized to undergo PCI with a drug-eluting stent (DES) or a placebo procedure at five study sites in the United Kingdom. More...
An assessment of cardiac function, including exercise time increment, was conducted at baseline and at six weeks of follow-up. The primary endpoint was difference in-between groups.

The results revealed similar improvements in exercise time with PCI (28.4 more seconds) compared to placebo (11.8 more seconds), and that most other endpoints yielded no differences either, including time to ST depression, change in peak oxygen uptake, change in the Seattle Angina Questionnaire (SAQ) physical limitation score, change in SAQ angina frequency and stability, quality of life, and the Duke treadmill score. The sole significant advantage of PCI was a greater improvement in dobutamine stress echocardiography (DSE) peak stress wall motion score index. The study was published on November 2, 2017, in The Lancet.

“Forgetting the potential magnitude of placebo effects prevents exploration of the inevitably complex relationship between anatomy, physiology, and symptoms,” concluded senior author Justin Davies, MD, and colleagues. “Clinicians have hoped there might be a simple entity named ischemia, which manifests as positive tests and clinical symptoms, and that treatment by PCI would eliminate all these manifestations concordantly; perhaps this notion is too optimistic.”

“We commend them for challenging the existing dogma around a procedure that has become routine, ingrained, and profitable. The results show once again why regulatory agencies, the medical profession, and the public must demand high-quality studies before the approval and adoption of new therapies,” commented David Brown, MD, and Rita Redberg, MD, in an accompanying editorial: “Based on these data, all cardiology guidelines should be revised to downgrade the recommendation for PCI in patients with angina, despite use of medical therapy.”

PCI, also known as coronary angioplasty, is a nonsurgical technique for treating obstructive coronary artery disease (CAD), unstable angina, and acute myocardial infarction (MI). It is usually performed by an interventional cardiologist, who feeds a catheter from the inguinal femoral artery or radial artery through the vasculature until they reach the site of blockage. X-ray imaging is used to guide the catheter threading. Angioplasty is then used to open the artery and allow blood flow, with stents used at to hold the artery open.

Related Links:
Imperial College London
Queen Mary, University of London

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.